Project Grant SUP30020GR0109

The National Science Foundation awarded a $195,381 Project Grant to Washington State University under the Biological Sciences program (CFDA 47.074) for the period of February 1, 2021 through January 31, 2024. The grant aims to fund the RAPID project "Curtailing Nosocomial Amplification of COVID-19," which seeks to develop epidemiological models to better understand and mitigate the transmission of COVID-19 in healthcare settings. As part of the grant, Research Triangle Institute will...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

This National Science Foundation Project Grant award of $525,000 supports research on concealing infectious disease at the University of Michigan from April 2022 through March 2025. The project aims to better understand decisions to conceal infectious illness and the psychological consequences of doing so. Specifically, the award will fund a series of descriptive studies and experiments to examine factors associated with concealing sickness from friends, coworkers, and strangers depending on...

The University of California, San Diego received a $250,000 Project Grant award from the National Science Foundation Office of Integrative Activities under the Integrative Activities federal grant program (CFDA 47.083) to evaluate COVID-19 mitigation strategies in schools using a spatially-explicit agent-based model of infection dynamics. The award, issued on October 1, 2021, will support research through September 30, 2023 to develop a computational model to simulate the spread of COVID-19...

Federal Cooperative Agreement Summary The National Center for Emerging and Zoonotic Infectious Diseases, a component of the Centers for Disease Control and Prevention (CDC), awarded a $675,000 Cooperative Agreement (IP25-111) to the University of Colorado-Denver, with performance in Colorado, effective September 1, 2025, through August 31, 2030. Under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084), this award supports the Rapid-Cycle Survey...

Federal Cooperative Agreement Summary The City of New York Department of Health and Mental Hygiene's Bureau of Immunization received a $8.03 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) to strengthen vaccine-preventable disease prevention and response efforts in New York City. The five-year award period runs from July 1, 2025, through June 30, 2030, and addresses declining...

The National Science Foundation Office of Integrative Activities awarded a $2 million Project Grant to Columbia University for the "COVID INFORMATION COMMONS EXTENSION FOR PANDEMIC RECOVERY" project. The grant was awarded on October 1, 2021 under the Integrative Activities program (CFDA 47.083) to enhance capacity for science and engineering and broaden participation in STEM research and education. Columbia University will use the funding over a four-year period ending September 30,...

This $300,000 Project Grant from the National Science Foundation's Office of International Science and Engineering will fund research collaboration between the United States and international partners on modeling human mobility patterns and contagion dynamics during the COVID-19 pandemic. Awarded on August 1, 2021 to The Research Foundation For The State University Of New York (SUNY) at Binghamton, the two-year grant aims to advance scientific discovery and international partnerships through...

Federal Cooperative Agreement Summary The County of Los Angeles Department of Public Health (DPH) received a $1.77M cooperative agreement from the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, under the CDC Investigations and Technical Assistance program (CFDA 93.283). The five-year award, effective July 1, 2025 through June 30, 2030, supports Los Angeles City's immunization and vaccine-preventable disease (VPD) control efforts....

Federal Cooperative Agreement Summary The District of Columbia Department of Health received a $3.8M Cooperative Agreement from the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases under CDC RFA IP25 0007, effective July 1, 2025 through June 30, 2030. This award supports comprehensive immunization program infrastructure enhancement and vaccine-preventable disease reduction across Washington, D.C. Key deliverables include expanded vaccine...